Continuing with their unique approach to cancer treatment, Cancer Treatment Center of America has joined with NantHealth and Allscripts to create Clinical Pathway. This is an all-inclusive and customized oncology treatment platform which basically streamlines, while augmenting, patient care.
According to Wikipedia, Chief Medical Officer at CTCA near Atlanta, GA, George Daneker, Jr, MD, “We created an ecosystem of treatment options, customized to the CTCA standard of care, for patients to review and choose from that’s safe and efficient.” Clinical Pathways is able to tally all pertinent information through the premier integration of eviti® platform and Allscripts Sunrise™ and provide a treatment plan individually customized to patient, their specific disease state, and provide comparisons between treatment options and average costs.
Cancer Treatment Centers of America, along with Allscripts and NantHealth, initiated planning of this project in early 2016 and is currently available in each of five locations, Georgia, Pennsylvania, Illinois, Arizona and Oklahoma. To paraphrase Bobby Reddy, Senior Executive Direction of Medical Affairs of NantHealth, more efficient communication provided by the collective technology is a game changer in cancer care covering prognosis, diagnosis and treatment.
Richard J. Stephenson watched his mother suffer and die from cancer. He was dissatisfied with the treatment options provided her and so founded Cancer Treatment Centers of America in 1988 in Zion, Illinois.The goal of CTCA was to provide cancer patients with customized care using the most up to date treatment and technology available, by cancer experts, on one campus.
The main thrust of CTCA’s treatment is an integrative, two-pronged approach to combating both the cancer and the side-effects. Conventional treatment, such as chemotherapy, is used to fight the cancer itself. Concurrently, what CTCA refers to as evidence-informed therapies, serve to manage side-effects. A few of these therapies are nutrition, mind-body and spiritual support.
For further information follow CTCA on Facebook.